Search Results - "Viero, Piera"

Refine Results
  1. 1
  2. 2

    Modern immunotherapy of adult B-lineage acute lymphoblastic leukemia with monoclonal antibodies and chimeric antigen receptor modified T cells by Maino, Elena, Scattolin, Anna Maria, Viero, Piera, Sancetta, Rosaria, Pascarella, Anna, Vespignani, Michele, Bassan, Renato

    “…The introduction of newer cytotoxic monoclonal antibodies and chimeric antigen receptor modified T cells is opening a new age in the management of B-lineage…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Current and future management of Ph/BCR-ABL positive ALL by Maino, Elena, Sancetta, Rosaria, Viero, Piera, Imbergamo, Silvia, Scattolin, Anna Maria, Vespignani, Michele, Bassan, Renato

    Published in Expert review of anticancer therapy (01-06-2014)
    “…Following the introduction of targeted therapy with tyrosine kinase inhibitors (TKI) at the beginning of the past decade, the outcome of patients with…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia by Bassan, Renato, Intermesoli, Tamara, Scattolin, Annamaria, Viero, Piera, Maino, Elena, Sancetta, Rosaria, Carobolante, Francesca, Gianni, Francesca, Stefanoni, Paola, Tosi, Manuela, Spinelli, Orietta, Rambaldi, Alessandro

    Published in Clinical lymphoma, myeloma and leukemia (01-07-2017)
    “…The study of minimal residual disease (MRD) in adult patients with acute lymphoblastic leukemia (ALL) allows a greater refinement of the individual risk…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Burkitt lymphoma in adolescents and young adults: management challenges by Dozzo, Massimo, Carobolante, Francesca, Donisi, Pietro Maria, Scattolin, Annamaria, Maino, Elena, Sancetta, Rosaria, Viero, Piera, Bassan, Renato

    “…About one-half of all Burkitt lymphoma (BL) patients are younger than 40 years, and one-third belong to the adolescent and young adult (AYA) subset, defined by…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Lymphomas occurring late after solid-organ transplantation: Influence of treatment on the clinical outcome by DOTTI, Gianpietro, FIOCCHI, Roberto, FERRAZZI, Paolo, REMUZZI, Giuseppe, BARBUI, Tiziano, RAMBALDI, Alessandro, MOTTA, Teresio, MAMMANA, Carmelo, GOTTI, Eliana, RIVA, Silvia, CORNELLI, Pieremilio, GRIDELLI, Bruno, VIERO, Piera, OLDANI, Elena

    Published in Transplantation (27-10-2002)
    “…Posttransplant lymphoproliferative disorders (PTLDs) that occur late after solid-organ transplantation are usually a monoclonal proliferation frequently…”
    Get full text
    Journal Article
  17. 17

    The management of acute myelogenous leukemia in the elderly: ten-year experience in 118 patients by Bassan, R, Buelli, M, Viero, P, Minotti, C, Barbui, T

    Published in Hematological oncology (01-09-1992)
    “…This retrospective study was undertaken to analyse the survival pattern of 118 consecutive, unselected patients with acute myelogenous leukemia (AML) aged…”
    Get more information
    Journal Article
  18. 18

    Multicentric Clinical Audit of Chemotherapy Administration for Lymphoprolipherative Diseases in Day Hospital Patient Setting by Muti, Giuliana Emilia, Rusconi, Chiara, Brizio, Anna, Turrini, Mauro, Viero, Piera, Iazzetta, Carmela, Terzi, Michela, Vener, Claudia, Corti, Consuelo, Giglio, Fabio, Nazzari, Morena, Fiamenghi, Cristina, Morra, Enrica

    Published in Blood (16-11-2008)
    “…Introduction Chemotherapy (CHT) administration is a high risk process. In particular, in the Day Hospital (DH) patient setting, the potential toxicity of…”
    Get full text
    Journal Article
  19. 19

    The Addition of Rituximab to High Dose Sequential Chemotherapy (HDS) Programs with Autologous Transplantation Significantly Improves the Outcome of Patients with Refractory or Relapsed B-Cell Non Hogkin's Lymphoma by Cortelazzo, Sergio, Rossi, Andrea, Carlotti, Emanuela, Viero, Piera, Rambaldi, Alessandro, Barbui, Tiziano

    Published in Blood (16-11-2005)
    “…The aim of the present study was to evaluate retrospectively the clinical outcome of 2 consecutive cohorts of relapsed/refractory NHL patients treated with HDS…”
    Get full text
    Journal Article
  20. 20

    High Risk of Severe Bleeding in Aged Patients With Chronic Idiopathic Thrombocytopenic Purpura by Cortelazzo, Sergio, Finazzi, Guido, Buelli, Maurizio, Molteni, Anna, Viero, Piera, Barbui, Tiziano

    Published in Blood (01-01-1991)
    “…The purpose of this study was to estimate the incidence and to establish which factors were associated with an increased risk of hemorrhagic complications in…”
    Get full text
    Journal Article